Hepatic fat changes with antisense oligonucleotide therapy targeting ANGPTL3.
Zimerman A, Wiviott SD, Park JG, Murphy SA, Ran X, Bramson CR, Curto M, Ramos V, Jevne A, Kuder JF, Verma S, Wojakowski W, Terra SG, Sabatine MS, Bergmark BA, Marston NA.
Zimerman A, et al.
J Clin Lipidol. 2024 Mar-Apr;18(2):e261-e268. doi: 10.1016/j.jacl.2023.12.001. Epub 2023 Dec 10.
J Clin Lipidol. 2024.
PMID: 38158248
Clinical Trial.